Unknown

Dataset Information

0

High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer.


ABSTRACT: This study aimed to investigate the association between serum YKL-40 and prognosis of breast cancer in a Chinese population. Expression of YKL-40 of 120 Chinese patients with breast cancer and 30 controls (benign breast lesions) was measured in tumor tissue by immunohistochemistry and in serum by ELISA. Differences in YKL-40 positivity grouped by specific patients' characteristics were compared using Pearson Chi-square test for rates of intratumoral staining, one-way ANOVA with a Bonferroni post-hoc comparison, or two-sample t-test for mean YKL-40 serum concentrations. Factors associated with overall survival were identified by univariate and multivariate cox-regression analyses. YKL-40 was elevated in approximately 75% of Chinese patients with breast cancer. A significantly higher percentage of patients with YKL-40 positive tumors had larger tumor size, higher TNM stage, and/or lymph node metastasis. Significantly higher mean YKL-40 serum concentrations were observed in patient subgroups with invasive lobular carcinoma (P<0.0167), higher TNM stage (P<0.001), and positive lymph node metastasis (P<0.001). The estimated mean survival time of patients with YKL-40 positive tumors was significantly shorter than for patients with YKL-40 negative tumors (55.13 months vs 65.78 months, P = 0.017). Multivariable Cox-regression analysis identified a significant association of overall survival time with YKL-40 serum concentration. Patients with YKL-40 positive tumors had significantly shorter disease free survival times than those with YKL-40 negative tumors. We propose that the potential utility of YKL-40 intratumoral staining or serum concentration as a biomarker for breast cancer is greatest within 5 years of diagnosis.

SUBMITTER: Wang D 

PROVIDER: S-EPMC3515550 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer.

Wang Dong D   Zhai Bo B   Hu Fengli F   Liu Chang C   Zhao Jinpeng J   Xu Jun J  

PloS one 20121205 12


This study aimed to investigate the association between serum YKL-40 and prognosis of breast cancer in a Chinese population. Expression of YKL-40 of 120 Chinese patients with breast cancer and 30 controls (benign breast lesions) was measured in tumor tissue by immunohistochemistry and in serum by ELISA. Differences in YKL-40 positivity grouped by specific patients' characteristics were compared using Pearson Chi-square test for rates of intratumoral staining, one-way ANOVA with a Bonferroni post  ...[more]

Similar Datasets

| S-EPMC5354916 | biostudies-literature
| S-EPMC7335588 | biostudies-literature
| S-EPMC4417200 | biostudies-literature
| S-EPMC6351153 | biostudies-literature
| S-EPMC8866556 | biostudies-literature
| S-EPMC3218924 | biostudies-literature
| S-EPMC5064386 | biostudies-literature
| S-EPMC7533750 | biostudies-literature
| S-EPMC5976691 | biostudies-literature
| S-EPMC6709285 | biostudies-literature